US Department of Defense supports an AlgiPharma initiated in vivo wound healing study on OligoG

AlgiPharma has together with Prof. Chandan Sen, at Ohio State University embarked on a study to investigate the effects of OligoG in a unique biofilm infected in vivo wound healing model.

For further information, please contact:
Philip D. Rye R&D Director; phil.rye@algipharma.com

August 2010